Commure Abruptly Ends Lucrative Referral Program for AI Software Following Intense Investigative Scrutiny.
admin Commure, a Silicon Valley health technology giant valued at approximately $7 billion, has officially shuttered...
Health
Eli Lilly targets booming black market for retatrutide
The rise of Khartis comes at a time when the "oralization" of immunology is one...
An investigation into Commure, and Medicare’s new-tech incentives for AI devices
The core challenge Commure seeks to solve is often referred to as the "administrative tax"...
The Lindsay Clancy case shows the limits of postpartum psychiatry
The discourse surrounding the Clancy case has frequently devolved into a binary struggle. To some,...
Safety Concerns Mount Over Neurocrine’s Vykat XR as Eli Lilly Targets Black-Market Sales of Experimental Obesity Drug
The pharmaceutical landscape is currently grappling with a dual crisis involving high-stakes metabolic treatments, as...
The Growing Gap: Why Cancer Patients Are Waiting Longer Than Ever for Life-Saving Treatment.
For a patient receiving a cancer diagnosis, the world undergoes a sudden and violent contraction....
WHO Officials Slam Trump Administration’s Vaccine Policy Overhaul as Politically Motivated and Scientifically Flawed.
In a sharp and rare rebuke of a member state’s domestic health policy, senior officials...
Trump Administration Unveils ‘Treatment First’ Strategy to Combat Addiction and Homelessness, Reversing Biden-Era Policies.
The Trump administration on Wednesday formally introduced a comprehensive new framework designed to address the...
Appeals Court Delivers Landmark Victory for Providers in No Surprises Act Dispute Over Payment Calculations.
In a decision that fundamentally reshapes the financial landscape of the American healthcare system, the...
Vaping and cannabis hit record highs among young adults in 2025: Survey
The 2025 data, released in mid-2026, reveals that the percentage of young adults who reported...
